Ayush market size crosses $18 billion EP News Bureau Nov 1, 2021 The latest RIS report pegs Ayush sector growth at 17 per cent during 2014-20
Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US EP News Bureau Oct 22, 2021 Express Scripts, a leading pharmacy benefit management organisation, will list Viatris-labelled biosimilar Insulin Glargine as a…
Pharma industry reports 105 deals worth $27 billion in September EP News Bureau Oct 7, 2021 The pharma industry reported 104 venture capital (VC) deals worth $3.5 billion in September 2021, compared to the last 12-month…
COVID-19 shapes Indian pharma deals landscape, reveals GlobalData report EP News Bureau Sep 21, 2021 Between 2019 and 2020, the deal number increased by 22 per cent, likely triggered by the COVID-19 pandemic
“Make in India” to fuel four-times growth in biosimilars and vaccines by 2026: CII-Kearney report EP News Bureau Sep 20, 2021 The report outlines that India is home to only eight per cent of the world’s biopharmaceutical market
Zydus Cadila gets USFDA approval for Vortioxetine Tablets EP News Bureau Sep 18, 2021 Vortioxetine is used to treat depression. It works by helping to restore the balance of a certain natural substance (serotonin) in…
Inter-changeable designation for Semglee in the US is a milestone achievement for Biocon Biologics Akanki Sharma Sep 6, 2021 Dr Arun Chandavarkar, Managing Director, Biocon Biologics talks to Akanki Sharma about his role and vision for the company, while…
Fidelity Health Services sets to venture into the US and EU markets EP News Bureau Aug 13, 2021 The company eyes the business revenue of $2 million in 2021-22
Demystifying pharma procurement: Opportunities, challenges and way forward EP News Bureau Aug 10, 2021 Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
Pharma industry reports 75 deals worth $26.6 billion in July 2021: GlobalData EP News Bureau Aug 6, 2021 The industry also reported 112 venture capital (VC) deals worth $3.8 billion in the same month
It’s important to enhance customer experience so that existing customers are more loyal Viveka Roychowdhury Aug 5, 2021 Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer…
Achieving Aatmanirbharta in APIs: Are we on the right track? Akanki Sharma Aug 2, 2021 As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector.…
Alembic Pharma Q1 net profit declines to Rs 165 cr Press Trust of India Jul 28, 2021 The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic…
Pack Expo Las Vegas to be held from 27th to 29th September, 2021 EP News Bureau Jul 20, 2021 During the expo, Antares Vision will be showcasing a variety of hardware and software solutions
Pharma industry’s digital maturity has accelerated with the adoption of digital engagement channels Viveka Roychowdhury Jul 18, 2021 Shashin Bodawala, Director – Business Excellence, Boehringer Ingelheim India updates Viveka Roychowdhury on the evolution of…
Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine EP News Bureau Jul 17, 2021 VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…
Lonza extends collaboration with biopharma client for antibody drug conjugate supply Reuters Jul 16, 2021 Lonza did not name the client with whom it extended the agreement
Ocugen seeks approval for Covaxin in Canada Press Trust of India Jul 16, 2021 The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…
Venus Remedies forays into consumer healthcare, launches R3SET for pain management EP News Bureau Jul 15, 2021 To introduce products covering key segments like pain management, gastro-enterology, hygiene, stress management, vitamins, and…
UK fines pharma companies $360 million for overcharging NHS Reuters Jul 15, 2021 The watchdog said the firms charged the NHS "excessively high prices" for almost a decade for the steroid hydrocortison